Xie F - Search Results

1

Design, Synthesis, and In Vitro Evaluation of the Photoactivatable Prodrug of the PARP Inhibitor Talazoparib.

Li J, Xiao D, Liu L, Xie F, Li W, Sun W, Yang X, Zhou X. Li J, et al. Among authors: xie f. Molecules. 2020 Jan 18;25(2):407. doi: 10.3390/molecules25020407. Molecules. 2020. PMID: 31963730 Free PMC article.

2

Asymmetric Synthesis and Absolute Configuration Assignment of a New Type of Bedaquiline Analogue.

Qiao CJ, Wang XK, Xie F, Zhong W, Li S. Qiao CJ, et al. Among authors: xie f. Molecules. 2015 Dec 11;20(12):22272-85. doi: 10.3390/molecules201219846. Molecules. 2015. PMID: 26690407 Free PMC article.

3

Design, synthesis and biological evaluation of 2-hydrazinyladenosine derivatives as A_2A adenosine receptor ligands.

Zhang M, Fan S, Zhou X, Xie F, Li S, Zhong W. Zhang M, et al. Among authors: xie f. Eur J Med Chem. 2019 Oct 1;179:310-324. doi: 10.1016/j.ejmech.2019.06.050. Epub 2019 Jun 24. Eur J Med Chem. 2019. PMID: 31255928

4

Novel Silyl Ether-Based Acid-Cleavable Antibody-MMAE Conjugates with Appropriate Stability and Efficacy.

Wang Y, Fan S, Xiao D, Xie F, Li W, Zhong W, Zhou X. Wang Y, et al. Among authors: xie f. Cancers (Basel). 2019 Jul 8;11(7):957. doi: 10.3390/cancers11070957. Cancers (Basel). 2019. PMID: 31288450 Free PMC article.

5

Design, Synthesis, and Renal Targeting of Methylprednisolone-Lysozyme.

Pan X, Xie F, Xiao D, Zhou X, Xiao J. Pan X, et al. Among authors: xie f. Int J Mol Sci. 2020 Mar 11;21(6):1922. doi: 10.3390/ijms21061922. Int J Mol Sci. 2020. PMID: 32168938 Free PMC article.

6

Antibody-Drug Conjugate Using Ionized Cys-Linker-MMAE as the Potent Payload Shows Optimal Therapeutic Safety.

Wang Y, Liu L, Fan S, Xiao D, Xie F, Li W, Zhong W, Zhou X. Wang Y, et al. Among authors: xie f. Cancers (Basel). 2020 Mar 21;12(3):744. doi: 10.3390/cancers12030744. Cancers (Basel). 2020. PMID: 32245171 Free PMC article.

7

The impact and mechanism of ampakine CX1739 on protection against respiratory depression in rats.

Xiao D, Xie F, Xu X, Zhou X. Xiao D, et al. Among authors: xie f. Future Med Chem. 2020 Dec;12(23):2093-2104. doi: 10.4155/fmc-2020-0256. Epub 2020 Oct 8. Future Med Chem. 2020. PMID: 33030058

8

A bifunctional molecule-based strategy for the development of theranostic antibody-drug conjugate.

Xiao D, Zhao L, Xie F, Fan S, Liu L, Li W, Cao R, Li S, Zhong W, Zhou X. Xiao D, et al. Among authors: xie f. Theranostics. 2021 Jan 1;11(6):2550-2563. doi: 10.7150/thno.51232. eCollection 2021. Theranostics. 2021. PMID: 33456559 Free PMC article.

9

Novel antibody-drug conjugate with UV-controlled cleavage mechanism for cytotoxin release.

Li J, Xiao D, Xie F, Li W, Zhao L, Sun W, Yang X, Zhou X. Li J, et al. Among authors: xie f. Bioorg Chem. 2021 Jun;111:104475. doi: 10.1016/j.bioorg.2020.104475. Epub 2020 Nov 16. Bioorg Chem. 2021. PMID: 33798843

10

Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation.

Xiao D, Luo L, Li J, Wang Z, Liu L, Xie F, Feng J, Zhou X. Xiao D, et al. Among authors: xie f. Bioorg Chem. 2021 Nov;116:105366. doi: 10.1016/j.bioorg.2021.105366. Epub 2021 Sep 17. Bioorg Chem. 2021. PMID: 34560561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,578 results

Search Page

Filters